NRP1 and neoplasm: Therefore, it can be inferred that PTX-SM-TAR has the targeting ability to NRP-1 and enter into cells through receptor-mediated endocytosis, which is helpful for PTX to target new blood vessels and tumor sites where NRP-1 is highly expressed.